Literature DB >> 11724791

Identification of residues at the alpha and epsilon subunit interfaces mediating species selectivity of Waglerin-1 for nicotinic acetylcholine receptors.

Brian E Molles1, Parastoo Rezai, Eric F Kline, Joseph J McArdle, Steven M Sine, Palmer Taylor.   

Abstract

Waglerin-1 (Wtx-1) is a 22-amino acid peptide that is a competitive antagonist of the muscle nicotinic receptor (nAChR). We find that Wtx-1 binds 2100-fold more tightly to the alpha-epsilon than to the alpha-delta binding site interface of the mouse nAChR. Moreover, Wtx-1 binds 100-fold more tightly to the alpha-epsilon interface from mouse nAChR than that from rat or human sources. Site-directed mutagenesis of residues differing in the extracellular domains of rat and mouse epsilon subunits indicates that residues 59 and 115 mediate the species difference in Wtx-1 affinity. Mutation of residues 59 (Asp in mouse, Glu in rat epsilon) and 115 (Tyr in mouse, Ser in rat epsilon) converts Wtx-1 affinity for the alpha-epsilon interface of one species to that of the other species. Studies of different mutations at position 59 indicate both steric and electrostatic contributions to Wtx-1 affinity, whereas at position 115, both aromatic and polar groups contribute to affinity. The human nAChR also has lower affinity for Wtx-1 than mouse nAChR, but unlike rat nAChR, residues in both alpha and epsilon subunits mediate the affinity difference. In human nAChR, polar residues (Ser-187 and Thr-189) confer low affinity, whereas in mouse nAChR aromatic residues (Trp-187 and Phe-189) confer high affinity. The overall results show that non-conserved residues at the nAChR binding site, although not crucial for activation by ACh, govern the potency of neuromuscular toxins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724791     DOI: 10.1074/jbc.M109232200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Novel antagonists of nicotinic acetylcholine receptors--proteins from venoms of Viperidae snakes.

Authors:  C A Vulfius; V G Starkov; T V Andreeva; V I Tsetlin; Yu N Utkin
Journal:  Dokl Biochem Biophys       Date:  2015-05-05       Impact factor: 0.788

2.  Block of postjunctional muscle-type acetylcholine receptors in vivo causes train-of-four fade in mice.

Authors:  M Nagashima; T Sasakawa; S J Schaller; J A J Martyn
Journal:  Br J Anaesth       Date:  2015-04-01       Impact factor: 9.166

3.  Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.

Authors:  Layla Azam; Athanasios Papakyriakou; Marios Zouridakis; Petros Giastas; Socrates J Tzartos; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2015-03-04       Impact factor: 4.436

Review 4.  End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease.

Authors:  Steven M Sine
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

5.  Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.

Authors:  Meredith F Ross; Aleksandra Filipovska; Robin A J Smith; Michael J Gait; Michael P Murphy
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

6.  Evolutionary Interpretations of Nicotinic Acetylcholine Receptor Targeting Venom Effects by a Clade of Asian Viperidae Snakes.

Authors:  Richard J Harris; Christina N Zdenek; Jordan Debono; David Harrich; Bryan G Fry
Journal:  Neurotox Res       Date:  2020-05-11       Impact factor: 3.911

7.  Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits.

Authors:  C J Hatton; C Shelley; M Brydson; D Beeson; D Colquhoun
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

Review 8.  Structural answers and persistent questions about how nicotinic receptors work.

Authors:  Gregg B Wells
Journal:  Front Biosci       Date:  2008-05-01

9.  Azemiopsin from Azemiops feae viper venom, a novel polypeptide ligand of nicotinic acetylcholine receptor.

Authors:  Yuri N Utkin; Christoph Weise; Igor E Kasheverov; Tatyana V Andreeva; Elena V Kryukova; Maxim N Zhmak; Vladislav G Starkov; Ngoc Anh Hoang; Daniel Bertrand; Joachim Ramerstorfer; Werner Sieghart; Andrew J Thompson; Sarah C R Lummis; Victor I Tsetlin
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

Review 10.  Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors.

Authors:  Ayaulym Bekbossynova; Albina Zharylgap; Olena Filchakova
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.